Working… Menu
Help guide our efforts to modernize
Send us your comments by March 14, 2020.

Acute Respiratory Distress Syndrome in Taiwan

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03260348
Recruitment Status : Not yet recruiting
First Posted : August 24, 2017
Last Update Posted : August 24, 2017
Information provided by (Responsible Party):
Chang Gung Memorial Hospital

Brief Summary:
The study enrolls ARDS patients in medical ICUs in 11 Hospitals in Taiwan. The epidemiology and long-term outcomes of the patients will be recorded.

Condition or disease
Acute Respiratory Distress Syndrome

Layout table for study information
Study Type : Observational
Estimated Enrollment : 2000 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Epidemiology and Long-term Outcomes of Patients With Acute Respiratory Distress Syndrome in Taiwan
Estimated Study Start Date : September 1, 2017
Estimated Primary Completion Date : January 31, 2018
Estimated Study Completion Date : January 31, 2023

Primary Outcome Measures :
  1. Epidemiology [ Time Frame: two months ]
    The incidence of ARDS in intensive care unit

  2. Mortality [ Time Frame: 90 days ]
    The mortality rate of patients in hospital

  3. Long-term outcome [ Time Frame: 5 years ]
    Performance status of live patients discharged.

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
All patients in medical intensive care unit during study period.

Inclusion Criteria:

  • Age >18 years
  • Patients in medical intensive care unit in Sep., 2017 and Jan., 2018.

Exclusion Criteria:

  • Age less than 18 years.
  • Pregnancy.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT03260348

Layout table for location contacts
Contact: Kuo-Chin Kao
Contact: Tsang-Tang Hsieh 886-3-3196200 ext 3711

Sponsors and Collaborators
Chang Gung Memorial Hospital
Layout table for investigator information
Principal Investigator: Kuo-Chin Kao Chang Gung Memorial Hospital

Layout table for additonal information
Responsible Party: Chang Gung Memorial Hospital Identifier: NCT03260348    
Other Study ID Numbers: 201701188B0
First Posted: August 24, 2017    Key Record Dates
Last Update Posted: August 24, 2017
Last Verified: August 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Respiratory Distress Syndrome, Newborn
Respiratory Distress Syndrome, Adult
Acute Lung Injury
Pathologic Processes
Lung Diseases
Respiratory Tract Diseases
Respiration Disorders
Infant, Premature, Diseases
Infant, Newborn, Diseases
Lung Injury